Clinical improvements and quality of life Among those patients who transitioned to exclusive HTP use, annual COPD exacerbations dropped from 2.1 to 1.3, while respiratory symptoms, measured via the COPD Assessment Test (CAT), showed consistent improvement
We believe this is appropriate because Section 351(i)(2) of the Public Health Service Act defines the terms biosimilar and biosimilarity to mean that a biosimilar is highly similar to its reference product, notwithstanding minor differences in clinically inactive components, and that there are no clinically meaningful differences between the biosimilar and the reference product in terms of the safety, purity, and potency of the product
Our progress in reducing the prevalence of smoking is undeniable, but our current efforts have become more symbol than substance
Larsson ML, Frisk M, Hallstrm J, Kiviloog J, Lundbck B: Environmental tobacco smoke exposure during childhood is associated with increased prevalence of asthma in adults
You should suspect a corneal abrasion if you have sustained an injury to your eye
